Enanta stockholders approve 1.6M share increase to 2019 Equity Plan; re-elect directors

ENANTA PHARMACEUTICALS INC

Stockholders re-elected Bruce L.A. Carter and Jay R. Luly as Class I directors with 20.3M and 24.7M votes for, respectively.
Amendment to 2019 Equity Incentive Plan approved (19.5M for, 5.4M against), increasing share reserve by 1,600,000 shares.
Advisory say-on-pay vote approved with 24.2M for, 692k against.
Ratification of PricewaterhouseCoopers as independent auditor for fiscal 2026 approved (26.8M for, 27k against).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.